Ignite Creation Date:
2025-12-25 @ 4:27 AM
Ignite Modification Date:
2025-12-26 @ 3:30 AM
Study NCT ID:
NCT03964220
Status:
COMPLETED
Last Update Posted:
2020-11-03
First Post:
2019-05-24
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Impact of Tiotropium Add-on Therapy in Patients With Asthma
Sponsor:
Boehringer Ingelheim
Organization:
Study Overview
Official Title:
The Effectiveness of Tiotropium Add-on Therapy Using a Real-world Cohort of Patients With Asthma
Status:
COMPLETED
Status Verified Date:
2020-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To evaluate the effectiveness of add on therapy with Tiotropium Respimat® compared to increasing the dose of ICS in patients with a diagnosis of Asthma and on ICS/LABA therapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: